Skip Nav Destination
Issues
Research Articles
Markers of Insulin Resistance and Colorectal Cancer Mortality
Maurizio Trevisan; on behalf of the Risk Factors and Life Expectancy Research Group; Jian Liu; on behalf of the Risk Factors and Life Expectancy Research Group; Paola Muti; on behalf of the Risk Factors and Life Expectancy Research Group; Giovanni Misciagna; on behalf of the Risk Factors and Life Expectancy Research Group; Alessandro Menotti; on behalf of the Risk Factors and Life Expectancy Research Group; Federica Fucci; on behalf of the Risk Factors and Life Expectancy Research Group
A Single Nucleotide Polymorphism in the 5′ Untranslated Region of RAD51 and Risk of Cancer among BRCA1/2 Mutation Carriers1
Wendy W. Wang; Amanda B. Spurdle; Prema Kolachana; Betsy Bove; Baruch Modan; Sarah M. Ebbers; Graeme Suthers; Margaret A. Tucker; David J. Kaufman; Michele M. Doody; Robert E. Tarone; Mary Daly; Hanoch Levavi; Heather Pierce; Angela Chetrit; kConFab; ABCFS/CFRBCS; AJBCS; NISOC; Galit Hirsh Yechezkel; Georgia Chenevix-Trench; Kenneth Offit; Andrew K. Godwin; Jeffery P. Struewing
Effect of Raloxifene on Breast Cancer Cell Ki67 and Apoptosis: A Double-Blind, Placebo-controlled, Randomized Clinical Trial in Postmenopausal Patients1
Mitch Dowsett; Nigel J. Bundred; Andrea Decensi; Richard C. Sainsbury; Yili Lu; Margaret J. Hills; Fredric J. Cohen; Paolo Veronesi; Mary E. R. O’Brien; Teri Scott; Douglas B. Muchmore
Polymorphisms of Two Fucosyltransferase Genes (Lewis and Secretor Genes) Involving Type I Lewis Antigens Are Associated with the Presence of Anti-Helicobacter pylori IgG Antibody1
Yuzuru Ikehara; Shoko Nishihara; Hisanori Yasutomi; Tabito Kitamura; Keitaro Matsuo; Nobuyuki Shimizu; Ken-ichi Inada; Yasuhiro Kodera; Yoshitaka Yamamura; Hisashi Narimatsu; Nobuyuki Hamajima; Masae Tatematsu
Single-Cell Gel (Comet) Assay Detects Primary DNA Damage in Nonneoplastic Urothelial Cells of Smokers and Ex-smokers1
Álisson M. de M. C. Gontijo; Flávia N. Elias; Daisy M. F. Salvadori; Maria Luiza C. S. de Oliveira; Luis A. Correa; José Goldberg; José Carlos de S. Trindade; João Lauro V. de Camargo
Short Communications
Correction
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds
